Group 1 - Medline Inc. (NASDAQ:MDLN) is a medical supplies distributor and medical device maker, which recently had a successful IPO priced at $29, with the stock rising to $41 on its first trading day [1] - The IPO market experienced a cooling-off period due to a government shutdown, which allowed for a self-correction and ultimately led to Medline's IPO being the largest deal in four years [1] - Currently, Medline's stock is trading at around $40, indicating a healthy performance post-IPO, and is considered a strong investment opportunity if the stock price decreases [1] Group 2 - Medline supplies medical and surgical products to hospitals, surgery centers, and other healthcare facilities, highlighting its role in the healthcare industry [2] - While Medline shows potential as an investment, there are AI stocks that are perceived to offer greater upside potential and lower downside risk [2]
Jim Cramer Medline: “It’s a Terrific Company”